1. Home
  2. FULC vs CCIX Comparison

FULC vs CCIX Comparison

Compare FULC & CCIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • CCIX
  • Stock Information
  • Founded
  • FULC 2015
  • CCIX 2023
  • Country
  • FULC United States
  • CCIX United States
  • Employees
  • FULC N/A
  • CCIX N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • CCIX
  • Sector
  • FULC Health Care
  • CCIX
  • Exchange
  • FULC Nasdaq
  • CCIX Nasdaq
  • Market Cap
  • FULC 469.0M
  • CCIX 389.0M
  • IPO Year
  • FULC 2019
  • CCIX 2024
  • Fundamental
  • Price
  • FULC $8.73
  • CCIX $10.77
  • Analyst Decision
  • FULC Buy
  • CCIX
  • Analyst Count
  • FULC 6
  • CCIX 0
  • Target Price
  • FULC $8.67
  • CCIX N/A
  • AVG Volume (30 Days)
  • FULC 524.6K
  • CCIX 201.2K
  • Earning Date
  • FULC 11-12-2025
  • CCIX 01-01-0001
  • Dividend Yield
  • FULC N/A
  • CCIX N/A
  • EPS Growth
  • FULC N/A
  • CCIX N/A
  • EPS
  • FULC N/A
  • CCIX 0.28
  • Revenue
  • FULC N/A
  • CCIX N/A
  • Revenue This Year
  • FULC N/A
  • CCIX N/A
  • Revenue Next Year
  • FULC N/A
  • CCIX N/A
  • P/E Ratio
  • FULC N/A
  • CCIX $37.81
  • Revenue Growth
  • FULC 2752.05
  • CCIX N/A
  • 52 Week Low
  • FULC $2.32
  • CCIX $10.02
  • 52 Week High
  • FULC $9.88
  • CCIX $11.66
  • Technical
  • Relative Strength Index (RSI)
  • FULC 54.66
  • CCIX 71.46
  • Support Level
  • FULC $9.10
  • CCIX $10.46
  • Resistance Level
  • FULC $9.88
  • CCIX $10.95
  • Average True Range (ATR)
  • FULC 0.57
  • CCIX 0.10
  • MACD
  • FULC -0.02
  • CCIX 0.03
  • Stochastic Oscillator
  • FULC 56.24
  • CCIX 63.27

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About CCIX Churchill Capital Corp IX Ordinary Shares

Churchill Capital Corp IX is a blank check company.

Share on Social Networks: